Fidelity International
AZN icon

Fidelity International’s AstraZeneca AZN Stock Holding History

Fidelity International’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840M Sell
4,492,612
-162,243
-3% -$30.5M 0.6% 39
2026
Q1 		$910M Buy
4,654,855
+4,654,488
+1,268,253% +$897M 0.71% 35
2025
Q4 		$67.4K Buy
367
+3
+0.8% +$526 ﹤0.01% 982
2025
Q3 		$55.8K Buy
364
+105
+41% +$15.9K ﹤0.01% 957
2025
Q2 		$36.2K Buy
259
+9
+4% +$1.26K ﹤0.01% 953
2025
Q1 		$36.7K Buy
250
+5
+2% +$723 ﹤0.01% 886
2024
Q4 		$32K Sell
245
-6
-2% -$840 ﹤0.01% 890
2024
Q3 		$39K Buy
251
+42
+20% +$6.78K ﹤0.01% 908
2024
Q2 		$32.6K Buy
209
+70
+50% +$10.5K ﹤0.01% 874
2024
Q1 		$18.8K Buy
139
+15
+12% +$1.99K ﹤0.01% 833
2023
Q4 		$16.6K Buy
124
+29
+31% +$3.77K ﹤0.01% 797
2023
Q3 		$12.9K Buy
95
+4
+4% +$546 ﹤0.01% 766
2023
Q2 		$13K Buy
91
+35
+63% +$5.15K ﹤0.01% 769
2023
Q1 		$7.71K Buy
56
+45
+409% +$6.05K ﹤0.01% 792
2022
Q4 		$1.42K Buy
11
+6
+120% +$752 ﹤0.01% 808
2022
Q3 		$1K Buy
+5
New +$634 ﹤0.01% 821
2015
Q3 		– Sell
-27,880
Closed -$1.78M – 509
2015
Q2 		$1.78M Hold
27,880
– – 0.01% 483
2015
Q1 		$1.91M Sell
27,880
-391,091
-93% -$27.2M 0.01% 455
2014
Q4 		$29.5M Sell
418,971
-498
-0.1% -$35.7K 0.1% 199
2014
Q3 		$30M Buy
419,469
+98,398
+31% +$7.2M 0.11% 180
2014
Q2 		$23.9M Sell
321,071
-23,113
-7% -$1.67M 0.09% 219
2014
Q1 		$22.3M Sell
344,184
-339,871
-50% -$22M 0.08% 238
2013
Q4 		$40.6M Buy
684,055
+160,694
+31% +$8.73M 0.16% 151
2013
Q3 		$27.2M Buy
+523,361
New +$26.3M 0.13% 170

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $148B AUM
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity International's AZN Position: Q2 2026 in Review

Fidelity International reduced its AstraZeneca (AZN) stake by 3.5% in Q2 2026, selling an estimated $30.5M and leaving 4,492,612 shares worth $840M. The position accounts for 0.6% of the portfolio, ranked #39.

Fidelity International first reported a position in AZN in Q3 2013 and has held it in 24 quarters since. The position peaked at $910M in Q1 2026. 1,296 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fidelity International held 4,492,612 shares of AstraZeneca worth $840M as of Q2 2026.
  • Fidelity International sold 162,243 AstraZeneca shares in Q2 2026, an estimated $30.5M.
  • AstraZeneca made up 0.6% of Fidelity International's portfolio in Q2 2026, its #39 holding.
  • Fidelity International first reported a position in AstraZeneca in Q3 2013 and has held it in 24 quarters since.
  • Fidelity International's AstraZeneca position peaked at $910M in Q1 2026.
  • 1,296 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.